Por favor, use este identificador para citar o enlazar este ítem: https://doi.org/10.14670/HH-18-301

Título: Farnesoid X receptor: a potential therapeutic target in multiple organs
Fecha de publicación: 2020
Editorial: Universidad de Murcia, Departamento de Biologia Celular e Histiologia
Cita bibliográfica: Histology and Histopathology Vol. 35, nº12 (2020)
ISSN: 0213-3911
1699-5848
Materias relacionadas: CDU::6 - Ciencias aplicadas::61 - Medicina::616 - Patología. Medicina clínica. Oncología
Palabras clave: Farnesoid X receptor
Bile acid
Metabolic homeostasis
Signaling pathways
Resumen: Farnesoid X receptor (FXR), a member of the nuclear receptor family, is a common receptor found in the intestine and liver, and helps to maintain systemic metabolic homeostasis through regulating bile acid, glucose, lipid metabolism, and energy homeostatsis. In addition, FXR regulates the functions of various organs, such as liver, intestine, kidney, breast, pancreas, cardiovascular system and brain. FXR also plays a key role in regulation of gut-microbiota through mediating the various signaling pathways. Accordingly, FXR has become an attractive therapeutic target in a variety of diseases. This review combines classical and recent research reports to introduce the basic information about FXR and its important roles in various organs of the body.
Autor/es principal/es: Zhang, Chao
Wang, Zixuan
Feng, Qingqing
Chen, Wei-Dong
Wang, Yan-Dong
URI: http://hdl.handle.net/10201/126587
DOI: https://doi.org/10.14670/HH-18-301
Tipo de documento: info:eu-repo/semantics/article
Número páginas / Extensión: 12
Derechos: info:eu-repo/semantics/openAccess
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Aparece en las colecciones:Vol.35,nº12 (2020)

Ficheros en este ítem:
Fichero Descripción TamañoFormato 
Zhang-35-1403-1414-2020.pdf1,21 MBAdobe PDFVista previa
Visualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons